ACE and type 2 diabetes mellitus: Over a follow-up period of 8 years, the proportion of subjects who developed type 2 diabetes were 2 (4.4%), 2 (4.3%) and 0 (0%) among ACE-inhibitors/CCBs/Thiazide-, ARBs/CCBs/Thiazide- and Perindopril/Amlodipine/Indapamide-treated patients, respectively.